Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-26-059409
Filing Date
2026-02-19
Accepted
2026-02-19 16:15:02
Documents
13
Period of Report
2025-10-31

Document Format Files

Seq Description Document Type Size
1 10-K/A engn-20251031.htm   iXBRL 10-K/A 862432
2 EX-31.3 engn-ex31_3.htm EX-31.3 14257
3 EX-31.4 engn-ex31_4.htm EX-31.4 14328
  Complete submission text file 0001193125-26-059409.txt   1289752

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT engn-20251031.xsd EX-101.SCH 74608
16 EXTRACTED XBRL INSTANCE DOCUMENT engn-20251031_htm.xml XML 13936
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 10-K/A | Act: 34 | File No.: 001-41854 | Film No.: 26654587
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)